<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05121532</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-11-12</org_study_id>
    <nct_id>NCT05121532</nct_id>
  </id_info>
  <brief_title>Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo</brief_title>
  <official_title>Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients with Non-segmental&#xD;
      Vitiligo before and after phototherapy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective study will include 30 patients with NSV, attending the Outpatient Clinics of&#xD;
      Dermatology at Sohag University Hospitals, as well as 30 normal volunteers as control.&#xD;
&#xD;
      This study will be submitted for approval by Research and Ethical committees at Sohag Faculty&#xD;
      of Medicine. An informed written consent will be obtained from each subject prior to&#xD;
      participation in the study after full explanation of the procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2022</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of Serum Interleukin-15 and Interleukin-22 Levels</measure>
    <time_frame>3 months</time_frame>
    <description>3 ml venous blood will be obtained from participante using commerciall available double antibody sandwich enzyme-linked immunosorbent assay (ELISA) kits to evaluate&#xD;
Serum IL15 level .&#xD;
Serum IL22 level. 3 ml venous blood will be obtained from participante using commerciall available double antibody sandwich enzyme-linked immunosorbent assay (ELISA) kits to evaluate&#xD;
1. Serum IL15 level . 2. Serum IL22 level.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Vitiligo</condition>
  <arm_group>
    <arm_group_label>non segmental vitiligo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>serum analysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal volunteer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>serum analysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Interleukin-15 and Interleukin-22</intervention_name>
    <description>Serum Interleukin-15 and Interleukin-22 in non segmental vitiligo</description>
    <arm_group_label>non segmental vitiligo</arm_group_label>
    <arm_group_label>normal volunteer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Patients suffering from non segmental vitiligo.&#xD;
&#xD;
               -  Patients not on medical treatment or phototherapy for vitiligo in the last 3&#xD;
                  months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Patients with systemic or cutaneous inflammatory disorders.&#xD;
&#xD;
               -  Patients on treatment for vitiligo in last 3 months.&#xD;
&#xD;
               -  Pregnant and lactating patients.&#xD;
&#xD;
               -  Patients with history of diabetes.&#xD;
&#xD;
               -  Patients with history of autoimmune diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 14, 2021</study_first_submitted>
  <study_first_submitted_qc>November 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2021</study_first_posted>
  <last_update_submitted>November 14, 2021</last_update_submitted>
  <last_update_submitted_qc>November 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Samah Saeed Badrous</investigator_full_name>
    <investigator_title>resident doctor at dermatology department balina central hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitiligo</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

